α-Synuclein in synaptic function and dysfunction

M Sharma, J Burré - Trends in neurosciences, 2023 - cell.com
Abstract α-Synuclein is a neuronal protein that is enriched in presynaptic terminals. Under
physiological conditions, it binds to synaptic vesicle membranes and functions in …

Microglia mediated neuroinflammation in Parkinson's disease

S Isik, B Yeman Kiyak, R Akbayir, R Seyhali, T Arpaci - Cells, 2023 - mdpi.com
Parkinson's Disease (PD) is the second most common neurodegenerative disorder seen,
especially in the elderly. Tremor, shaking, movement problems, and difficulty with balance …

The link between neuroinflammation and the neurovascular unit in synucleinopathies

Q Wang, J Zheng, S Pettersson, R Reynolds… - Science advances, 2023 - science.org
The neurovascular unit (NVU) is composed of vascular cells, glial cells, and neurons. As a
fundamental functional module in the central nervous system, the NVU maintains …

Alpha-synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches

M Vidović, MG Rikalovic - Cells, 2022 - mdpi.com
Following Alzheimer's, Parkinson's disease (PD) is the second-most common
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …

[HTML][HTML] Recent developments in the treatment of Parkinson's Disease

TB Stoker, RA Barker - F1000Research, 2020 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is a common neurodegenerative disease typified by a movement
disorder consisting of bradykinesia, rest tremor, rigidity, and postural instability. Treatment …

Microglia response during Parkinson's disease: alpha-synuclein intervention

SA Ferreira, M Romero-Ramos - Frontiers in cellular neuroscience, 2018 - frontiersin.org
The discovery of the central role played by the protein alpha-synuclein in Parkinson's
disease and other Lewy body brain disorders has had a great relevance in the …

Immune system responses in Parkinson's disease: early and dynamic

MG Tansey, M Romero‐Ramos - European Journal of …, 2019 - Wiley Online Library
The neuropathological hallmarks of Parkinson's disease (PD) are the degeneration and
death of dopamine‐producing neurons in the ventral midbrain, the widespread …

Systemic exosomal delivery of shRNA minicircles prevents parkinsonian pathology

M Izco, J Blesa, M Schleef, M Schmeer, R Porcari… - Molecular Therapy, 2019 - cell.com
The development of new therapies to slow down or halt the progression of Parkinson's
disease is a health care priority. A key pathological feature is the presence of alpha …

Prion-like mechanisms in Parkinson's disease

J Ma, J Gao, J Wang, A Xie - Frontiers in neuroscience, 2019 - frontiersin.org
Formation and aggregation of misfolded proteins in the central nervous system (CNS) is a
key hallmark of several age-related neurodegenerative diseases, including Parkinson's …

Functional and pathological effects of α-synuclein on synaptic SNARE complexes

V Gao, JA Briano, LE Komer, J Burré - Journal of molecular biology, 2023 - Elsevier
Abstract α-Synuclein is an abundant protein at the neuronal synapse that has been
implicated in Parkinson's disease for over 25 years and characterizes the hallmark …